Biostar Pharmaceuticals (BSPM) announced after the bell Tuesday that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-3, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on April 4, 2012.
Biostar Pharmaceuticals has gapped open sharply higher Wednesday morning and is now up 1.01 at $1.61. The stock has set a 10 1/2 month high.
by RTT Staff Writer
For comments and feedback: email@example.com